Spravato (Esketamine)

If you’ve struggled with major depression and haven’t found relief through traditional antidepressants, Spravato® may offer a new path forward. Spravato® (esketamine) is an FDA-approved nasal spray designed for adults with treatment-resistant depression (TRD) and, in some cases, major depressive disorder with suicidal thoughts or behavior.

Unlike conventional antidepressants, which can take weeks to work, Spravato® begins targeting symptoms within hours or days. Administered under medical supervision in our office, Spravato® works on different brain pathways to help restore balance—offering renewed hope for patients who’ve tried everything else.